PK/PD studies

Advanced Pharma – Miami is a Phase I clinical research facility in Miami, Florida, advancing medicine since 1992. It has completed more than 150 clinical trials and specializes in research across Phases I through IV, including First-in-Human trials, led by experienced Physician Investigators. The facility offers on-site FibroScan services for NASH, NAFLD, and hepatic impairment studies.

bioavailability/bioequivalenceCLIA waived labclinical pharmacologyFibroScan liver diagnosticsFirst-in-Human trialson-site pharmacypatient recruitmentPhase I clinical trialstelemetry and Holter monitoring

Biocytogen is a global provider of animal and cell model generation for preclinical research, offering gene-edited and humanized mouse models, cell lines, and integrated drug discovery services. Through its BioMice brand it supplies off-the-shelf and custom animal models, and it develops fully human antibody discovery platforms including the RenMice family (RenMab, RenLite, RenNano, RenTCRmimic, RenMice KO) based on its SUPCE gene-editing technology.

antibody discoverycolony management and breedingcryopreservationgene editinghumanized mouse modelsin vitro pharmacologyin vivo pharmacologyknockout/knockin mouse model generationnon-GLP toxicity studiesrederivation

Flourish Research is a wholly owned clinical trial site network with sites across the United States, conducting studies spanning all phases of research. It is known for reliable, predictable, and rapid patient recruitment and is recognized as a leader in patient retention. The company provides patient-centric care and facilitates patient-researcher partnerships in communities across the country.

accredited sleep labsbioequivalence studiescryopreservationECGFirst-in-Human studiesinpatient/overnight unitsIV infusion dosing/monitoringPBMC processingPhase I-IV clinical trialsSAD/MAD studies

GemPharmatech provides preclinical research services and genetically engineered animal models for drug discovery. Its offering centers on an extensive library of over 800 well-characterized drug-screening mouse and rat models, with a repository spanning nearly 30,000 genetically engineered mouse strains maintained under SPF conditions. The company supports preclinical studies across therapeutic areas including oncology, metabolic disease, cardiovascular, autoimmune, neuroscience, infectious disease, respiratory, and rare diseases.

antibody discoverybehavioral analysiscustom breeding and colony managementFlow Cytometrygenetically engineered mouse model generationimaging and analysisin vitro assaysmolecular testingpreclinical efficacy evaluationpreclinical pathology